Choate represented Victress Capital in the transaction. Droplette, the consumer skincare technology originally developed as a medical device to treat rare and debilitating skin diseases, executed...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here